Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by pierre013on Nov 29, 2016 12:15pm
202 Views
Post# 25527853

RE:francois21, Pierre 13 can you comment on the financing....

RE:francois21, Pierre 13 can you comment on the financing....
Josh19 wrote: I personally think that PLI does not need financing judging from PL's recent e-mail (shared by sah1).  However, several posters seem to think that it is very likely if not inevitable in their opinion.

Can you make some comments regarding this?  

Also about the concerns that PLI has too many shares outstanding?  Again, I do not think that it is a problem, but this is not my area of expertise, so would really appreciate you guys's comments.

Thanks.


I would say that companies do financing when nobody thinks we'll get one. From what I see right now, one or 2 partnership deals before the end of 2017 should avoid any financing. For the plant in Great Britain, like Francois said, PLI won't need to put any big money on it before 2022. Fear and greed are the 2 extremes the big players (short sellers) like to play with the retail investors. We just pass trough it in the last few weeks. Did I sell any share during this time? No, because I got caught off guard in the past trying to guess the timing and lost almost every time. So now I relax and close my eyes until the things settle down. Do I get frustrated ? Yes but I did not lose any money in the last 4 weeks and now the SP is on its next leg up. For the number of shares, it does not influence the real value of the company but I know that PLI management would like to get more institutional investors to stabilize the float.
Bullboard Posts